Anpario (LON:ANP) Announces Quarterly Earnings Results

Anpario (LON:ANPGet Free Report) posted its quarterly earnings data on Monday. The company reported GBX 28.40 ($0.37) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Anpario had a net margin of 9.23% and a return on equity of 8.74%.

Anpario Price Performance

Shares of Anpario stock traded down GBX 9.05 ($0.12) during mid-day trading on Wednesday, reaching GBX 378.45 ($4.89). 42,236 shares of the stock were exchanged, compared to its average volume of 51,795. Anpario has a fifty-two week low of GBX 229.50 ($2.97) and a fifty-two week high of GBX 488.55 ($6.32). The company has a market cap of £64.57 million, a price-to-earnings ratio of 20.90 and a beta of 0.58. The firm has a 50-day simple moving average of GBX 432.58 and a 200 day simple moving average of GBX 377.46. The company has a current ratio of 6.15, a quick ratio of 5.16 and a debt-to-equity ratio of 0.10.

Anpario Increases Dividend

The company also recently announced a dividend, which will be paid on Friday, July 25th. Stockholders of record on Thursday, July 10th will be paid a GBX 8 ($0.10) dividend. This represents a dividend yield of 2.09%. The ex-dividend date is Thursday, July 10th. This is an increase from Anpario’s previous dividend of $3.25. Anpario’s payout ratio is currently 60.74%.

Insiders Place Their Bets

In other Anpario news, insider Marc Wilson bought 3,778 shares of the firm’s stock in a transaction dated Tuesday, April 1st. The shares were bought at an average price of GBX 398 ($5.15) per share, for a total transaction of £15,036.44 ($19,439.48). Insiders own 30.51% of the company’s stock.

Wall Street Analysts Forecast Growth

ANP has been the topic of several research reports. Canaccord Genuity Group boosted their price target on Anpario from GBX 380 ($4.91) to GBX 500 ($6.46) and gave the company a “buy” rating in a research note on Tuesday, January 14th. Shore Capital restated a “house stock” rating on shares of Anpario in a research report on Monday.

Get Our Latest Research Report on ANP

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Featured Stories

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.